Shelley Potter
University of Bristol
SurgeryRandomized controlled trialPhysical therapyProspective cohort studyMedical physicsAuditCohort studyPatient satisfactionBreast surgeryMastectomyMEDLINEQuality of life (healthcare)Protocol (science)Breast reconstructionMammaplastyImplantRadiation therapyFamily medicineBreast cancerGeneral surgeryMedicine
123Publications
17H-index
914Citations
Publications 122
Newest
#1Kerry N L Avery (University Hospitals Bristol NHS Foundation Trust)
#2Nicholas Wilson (UoB: University of Bristol)H-Index: 3
Last. Shelley Potter (UoB: University of Bristol)H-Index: 17
view all 0 authors...
Objective null To develop a core outcome set (COS), an agreed minimum set of outcomes to measure and report in all studies evaluating the introduction and evaluation of novel surgical techniques. null Summary background data null Agreement on the key outcomes to measure and report for safe and efficient surgical innovation is lacking, hindering transparency and risking patient harm. null Methods null (I) Generation of a list of outcome domains from published innovation-specific literature, polic...
Source
#1Raghavan Vidya (University of Wolverhampton)H-Index: 10
#2Daniel Leff (Imperial College London)H-Index: 26
Last. Christopher HolcombeH-Index: 19
view all 16 authors...
BACKGROUND Future innovations in science and technology with an impact on multimodal breast cancer management from a surgical perspective are discussed in this narrative review. The work was undertaken in response to the Commission on the Future of Surgery project initiated by the Royal College of Surgeons of England. METHODS Expert opinion was sought around themes of surgical de-escalation, reduction in treatment morbidities, and improving the accuracy of breast-conserving surgery in terms of m...
Source
#1Lisa Whisker (NUH: Nottingham University Hospitals NHS Trust)H-Index: 8
#2Matthew Barber (Western General Hospital)H-Index: 8
Last. Shelley Potter (North Bristol NHS Trust)H-Index: 17
view all 9 authors...
These guidelines have been produced with the involvement of the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons. Recommendations have been derived after a review of published data regarding the use of acellular dermal matrix (ADM), biological and synthetic mesh in breast reconstruction. The guidelines represent a consensus opinion on the optimal management of patients having biological or synthetic mesh assisted breast reconstruction in...
Source
#1Timothy SchrireH-Index: 1
Last. Shelley PotterH-Index: 17
view all 3 authors...
Source
#1Emma Sewart (UoB: University of Bristol)
#2Nicholas Turner (UoB: University of Bristol)H-Index: 9
Last. Shelley Potter (UoB: University of Bristol)H-Index: 17
view all 10 authors...
Source
#1Emma Sewart (UoB: University of Bristol)
#2Nicholas Turner (UoB: University of Bristol)H-Index: 9
Last. Shelley Potter (UoB: University of Bristol)H-Index: 17
view all 10 authors...
Source
#1Charlotte F Davies (UoB: University of Bristol)H-Index: 11
#2Christopher Holcombe (University of Liverpool)H-Index: 19
Last. Shelley Potter (UoB: University of Bristol)H-Index: 17
view all 12 authors...
Introduction Approximately 40% of the 55 000 women diagnosed with breast cancer each year in the UK undergo mastectomy because they are considered unsuitable for standard breast-conserving surgery (BCS) due to tumour size or multiple tumour foci. Mastectomy can significantly impact women’s quality of life, and only one in four women currently undergo immediate breast reconstruction (IBR). Level 2 oncoplastic breast-conserving surgery (OPBCS) combines removing the cancer with a range of plastic s...
Source
#1Rajiv Dave (University of Manchester)H-Index: 14
#1RV Dave (University of Manchester)H-Index: 3
view all 22 authors...
The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Of 3776 patients (from 64 UK units) in the st...
Source
#1J Banks (RD&E: Royal Devon and Exeter Hospital)
#1Jenny BanksH-Index: 2
Last. S Lo
view all 61 authors...
Background Breast angiosarcomas are rare tumours of vascular origin. Secondary angiosarcoma occurs following radiotherapy for breast cancer. Angiosarcomas have high recurrence and poor survival rates. This is concerning owing to the increasing use of adjuvant radiotherapy for the treatment of invasive breast cancer and ductal cancer in situ (DCIS), which could explain the rising incidence of angiosarcoma. Outcome data are limited and provide a poor evidence base for treatment. This paper present...
Source
#1Walter P. WeberH-Index: 33
Last. Alexandra SchulzH-Index: 1
view all 42 authors...
Background The emphasis on aesthetic outcomes and quality of life (QoL) has motivated surgeons to develop skin- and nipple-sparing mastectomy (SSM/NSM) for breast cancer (BC) treatment or prevention. Immediate breast reconstruction is based on implants or autologous tissue. The optimal positioning of the implant is not clear: While pre-pectoral positioning respects the anatomic position of the mammary gland and avoids surgery-induced alterations of the pectoralis major muscle, the lack of muscle...
Source